Keyphrases
Prostate Cancer Survival
100%
Population-based Cohort
100%
Allopurinol
100%
Finnish Population
100%
Prostate Cancer
50%
Overall Survival
41%
Prostate Cancer Risk
25%
Cancer-specific Survival
16%
Working Diagnosis
16%
In Cancer
16%
Medical Records
8%
Tumor Stage
8%
Cancer Clinical Trials
8%
Adjusted Hazard Ratio
8%
Charlson Comorbidity Index
8%
Extended Cox Regression
8%
Uric Acid
8%
Anticancer Effect
8%
Anticarcinogenic Properties
8%
Metabolic Problems
8%
Arm Use
8%
Multivariable
8%
Acid Formation
8%
Social Insurance
8%
Taiwanese
8%
Cancer Cases
8%
Finland
8%
Age at Diagnosis
8%
Newly Diagnosed
8%
No Significant Difference
8%
Prescription Registry
8%
Gout
8%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Allopurinol
100%
Cancer Survival
100%
Overall Survival
41%
Cancer Specific Survival
25%
Cohort Study
8%
Comorbidity
8%
Cancer Incidence
8%
Cancer Staging
8%
Uric Acid
8%
Gout
8%
Immunology and Microbiology
Allopurinol
100%
Cancer Survival
100%
Prostate
58%
Overall Survival
41%
Cancer Specific Survival
25%
Arm
8%
Comorbidity
8%
Cancer Incidence
8%
High Risk Population
8%
Medical Record
8%
Cancer Staging
8%
Gout
8%